The final, formatted version of the article will be published soon.
OPINION article
Front. Immunol.
Sec. Viral Immunology
Volume 15 - 2024 |
doi: 10.3389/fimmu.2024.1462628
Association of IFNAR2 and TYK2 with COVID-19 pathology: current and future
Provisionally accepted- 1 Research Center for Clinical Virology, Tehran University of Medical Sciences, Tehran, Iran
- 2 Student Research Committee, School of Medicine, Mazandaran University of Medical Sciences, Sari, Mazandaran, Iran
- 3 Gastrointestinal Cancer Research Center, Non-communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Mazandaran, Iran
- 4 Department of Molecular Predictive Medicine and Sport Science, Kyorin University Faculty of Medicine, Mitaka, Japan, Mitaka, Japan
Keywords: coronavirus disease 2019, Prognostic factor, Tyrosine Kinase, interferon alpha-beta receptor subunit 2 (IFNAR2), SARS coronavirus 2
Received: 11 Jul 2024; Accepted: 02 Sep 2024.
Copyright: © 2024 Razavi, Raei and Shirato. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Ken Shirato, Department of Molecular Predictive Medicine and Sport Science, Kyorin University Faculty of Medicine, Mitaka, Japan, Mitaka, Japan
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.